The neurological manifestations of HIV infection may be in part due to alte
rations in the blood-brain barrier. These may be caused hy structural chang
es in the barrier or may consist of subtle metabolic or biochemical disturb
ances in barrier function. In the CNS, the family of glucose transporter pr
oteins plays a key role in controlling movement of glucose across cell memb
ranes. The 55 kDa isoform of glucose transporter 1 (GLUT1) regulates import
of glucose from blood to brain across the endothelial cells of the blood-b
rain barrier (BBB), whereas the 45 kDa form of GLUT1 predominantly regulate
s nonvascular glial glucose uptake. In this study, expression of 55 and 45
kDa forms of GLUT1 in different regions of the brain from 18 SIV-infected m
acaques was measured by quantitative immunoblot and then compared with the
severity of SIV encephalitis to determine whether neurologic disease is rel
ated to altered glucose metabolism at the BBB and in brain parenchyma. An i
nverse relationship was found between severity of SIV encephalitis and expr
ession of the endothelial 55 kDa isoform of GLUT1 at the BBB in cortical gr
ey matter, caudate nucleus, and cerebellum A similar relationship also was
found for the glial 45 kDa GLUT1 isoform in cortical grey matter. In additi
on, a significant increase in 55 kDa GLUT1 expression was found in caudate
nucleus during the early stages of infection. In the brains of macaques wit
h moderate to severe encephalitis, 55 kDa GLUT1 expression had declined to
pre-infection levels. These GLUT1 alterations at the BBB and in glial cells
may reflect severe disturbances in the CNS microenvironment that contribut
e to CNS dysfunction.